New Medical Center Ad Focuses on Groundbreaking Discoveries and Innovations

The University of Maryland Medical Center is home to many nationally and internationally recognized physicians and scientists who perform pioneering research, and use the latest state-of-the-art technologies to advance the field of medicine and save lives. We bring together laboratory scientists and clinical investigators to better understand disease, develop new methods of treatment, and translate research results into clinical practice. At the University of Maryland Medical Center, ground-breaking discoveries are happening every day.

Watch the ads that highlight our Medical Center innovations above, and the University of Maryland Children's Hospital, here.


Dr. Angela BrodieCancer Therapies

Aromatase inhibitors stop the production of estrogen that fuels the growth of cancer cells, and are widely used to treat postmenopausal women with hormone-responsive breast cancer. University of Maryland Marlene and Stewart Greenebaum Cancer Center research scientist, Dr. Angela Brodie, pioneered the development of this new class of drugs, which have also shown promise in preventing breast cancer in high-risk patients. Click here for more information


Genetic TestingGenetic Testing

As part of a new personalized medicine initiative, the Medical Center offers genetic testing to help doctors determine which medication a patient should take after a stenting procedure in order to prevent blood clots that could lead to serious - and potentially fatal - heart attacks and strokes. This gene-testing initiative for cardiology patients is spearheaded by Dr. Alan Shuldiner, Director of the Program in Personalized and Genomic Medicine at the University of Maryland School of Medicine. Click here for more information on the University of Maryland Gene-Testing Initiative.


Vaccines and Infectious DiseaseVaccines and Infectious Disease

Fighting infectious disease is a key area for basic science research. Stefanie Vogel, PhD, professor in the departments of Microbiology and Immunology Medicine, is part of a team that found an experimental drug can treat influenza and prevent virus-induced lung injury and death, even when administered days after initial infection.


Lung Perfusion ProgramLung Perfusion Program

The University of Maryland Lung Transplant Team is the first in the country to use ex vivo lung perfusion to repair donor lungs prior to transplantation. This out-of-the-body technique in which donor lungs are evaluated and repaired, increases the donor lung pool significantly and provides more transplantable lungs to more than 1,700 on the waiting list. Click here for more information on the Lung Perfusion Program.


Minimally Invasive Ventricular Assist Device ImplantationMinimally Invasive Ventricular Assist Device Implantation

Cardiac surgeons at the University of Maryland Heart Center have implanted a ventricular assist device using a minimally invasive technique that employs small openings in the chest, a patient-friendly approach that provides the same results as traditional chest-splitting, open-heart surgery for heart pump implantation. For the patient, the new technique means quicker recovery, reduced chance of infection and minimal blood loss. Click here for more information about this procedure.

This page was last updated: March 25, 2014

         
Average rating (0)